☰

Ivana Bozic, Ph.D. - Publications

Affiliations: 
Mathematics Harvard University, Cambridge, MA, United States 
Area:
Evolutionary Dynamics
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mamis K, Zhang R, Bozic I. Stochastic model for cell population dynamics quantifies homeostasis in colonic crypts and its disruption in early tumorigenesis. Proceedings. Biological Sciences. 290: 20231020. PMID 37848058 DOI: 10.1098/rspb.2023.1020  0.351
2023 Woolston DW, Lee ND, Shadman M, Latorre-Esteves E, Tee XR, Fredrickson J, Kohrn BF, Ujjani C, Eckel A, Till B, Fang M, Radich J, Bozic I, Risques RA, Yeung CCS. Ultra-deep mutational landscape in chronic lymphocytic leukemia uncovers dynamics of resistance to targeted therapies. Haematologica. PMID 37706363 DOI: 10.3324/haematol.2023.283372  0.342
2023 Zhang R, Ukogu OA, Bozic I. Waiting times in a branching process model of colorectal cancer initiation. Theoretical Population Biology. 151: 44-63. PMID 37100121 DOI: 10.1016/j.tpb.2023.04.001  0.374
2023 Lee ND, Kaveh K, Bozic I. Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data. Seminars in Cancer Biology. 92: 61-73. PMID 37023969 DOI: 10.1016/j.semcancer.2023.04.002  0.325
2022 Lee ND, Bozic I. Inferring parameters of cancer evolution in chronic lymphocytic leukemia. Plos Computational Biology. 18: e1010677. PMID 36331987 DOI: 10.1371/journal.pcbi.1010677  0.453
2022 Paterson C, Bozic I, Smith MJ, Hoad X, Evans DGR. A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannoma. British Journal of Cancer. PMID 36097176 DOI: 10.1038/s41416-022-01955-8  0.564
2022 Bozic I. Quantification of the Selective Advantage of Driver Mutations Is Dependent on the Underlying Model and Stage of Tumor Evolution. Cancer Research. 82: 21-24. PMID 34983781 DOI: 10.1158/0008-5472.CAN-21-1064  0.364
2020 Bozic I, Wu CJ. Delineating the evolutionary dynamics of cancer from theory to reality. Nature Cancer. 1: 580-588. PMID 35121980 DOI: 10.1038/s43018-020-0079-6  0.384
2020 Paterson C, Clevers H, Bozic I. Mathematical model of colorectal cancer initiation. Proceedings of the National Academy of Sciences of the United States of America. 117: 20681-20688. PMID 32788368 DOI: 10.1073/Pnas.2003771117  0.689
2019 Bozic I, Paterson C, Waclaw B. On measuring selection in cancer from subclonal mutation frequencies. Plos Computational Biology. 15: e1007368. PMID 31557163 DOI: 10.1371/Journal.Pcbi.1007368  0.718
2019 Gruber M, Bozic I, Leshchiner I, Livitz D, Stevenson K, Rassenti L, Rosebrock D, Taylor-Weiner A, Olive O, Goyetche R, Fernandes SM, Sun J, Stewart C, Wong A, Cibulskis C, et al. Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature. PMID 31142838 DOI: 10.1038/S41586-019-1252-X  0.49
2017 Landau DA, Sun C, Rosebrock D, Herman SEM, Fein J, Sivina M, Underbayev C, Liu D, Hoellenriegel J, Ravichandran S, Farooqui MZH, Zhang W, Cibulskis C, Zviran A, Neuberg DS, ... ... Bozic I, et al. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. Nature Communications. 8: 2185. PMID 29259203 DOI: 10.1038/S41467-017-02329-Y  0.397
2017 Reiter JG, Makohon-Moore AP, Gerold JM, Bozic I, Chatterjee K, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA. Reconstructing metastatic seeding patterns of human cancers. Nature Communications. 8: 14114. PMID 28139641 DOI: 10.1038/Ncomms14114  0.494
2017 Makohon-Moore AP, Zhang M, Reiter JG, Bozic I, Allen B, Kundu D, Chatterjee K, Wong F, Jiao Y, Kohutek ZA, Hong J, Attiyeh M, Javier B, Wood LD, Hruban RH, et al. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nature Genetics. PMID 28092682 DOI: 10.1038/Ng.3764  0.599
2016 Yamamoto Y, Offord CP, Kimura G, Kuribayashi S, Takeda H, Tsuchiya S, Shimojo H, Kanno H, Bozic I, Nowak MA, Bajzer Ž, Dingli D. Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy. British Journal of Cancer. 115: 195-202. PMID 27404586 DOI: 10.1038/Bjc.2016.171  0.469
2016 Burger JA, Landau DA, Taylor-Weiner A, Bozic I, Zhang H, Sarosiek K, Wang L, Stewart C, Fan J, Hoellenriegel J, Sivina M, Dubuc AM, Fraser C, Han Y, Li S, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nature Communications. 7: 11589. PMID 27199251 DOI: 10.1038/Ncomms11589  0.535
2016 Bozic I, Gerold JM, Nowak MA. Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. Plos Computational Biology. 12: e1004731. PMID 26828429 DOI: 10.1371/Journal.Pcbi.1004731  0.644
2016 Reiter JG, Makohon-Moore AP, Gerold JM, Bozic I, Chatterjee K, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA. Abstract 2374: Reconstructing the evolutionary history of metastatic cancers Cancer Research. 76: 2374-2374. DOI: 10.1158/1538-7445.Am2016-2374  0.467
2015 Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, Böttcher S, Carter SL, Cibulskis K, Mertens D, Sougnez CL, Rosenberg M, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 526: 525-30. PMID 26466571 DOI: 10.1038/Nature15395  0.576
2015 Misale S, Bozic I, Tong J, Peraza-Penton A, Lallo A, Baldi F, Lin KH, Truini M, Trusolino L, Bertotti A, Di Nicolantonio F, Nowak MA, Zhang L, Wood KC, Bardelli A. Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers. Nature Communications. 6: 8305. PMID 26392303 DOI: 10.1038/Ncomms9305  0.55
2015 Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature. 525: 261-4. PMID 26308893 DOI: 10.1038/Nature14971  0.697
2015 Landau DA, Tausch E, Böttcher S, Stewart C, Bozic I, Leischner I, Rosebrock D, Taylor-Weiner A, Mertens D, Sougnez C, Kless S, Kneba M, Ritgen M, Kluth S, Bahlo J, et al. Quantitative Clonal Dynamics Define Mechanisms of CLL Evolution in Response to Combination Chemotherapy Blood. 126: 362-362. DOI: 10.1182/Blood.V126.23.362.362  0.526
2015 Makohon-Moore AP, Zhang M, Reiter JG, Bozic I, Wong F, Jiao Y, Chatterjee K, Nowak MA, Papadopoulos N, Vogelstein B, Kinzler KW, Iacobuzio-Donahue CA. Abstract 4137: Clonal evolution defines the natural history of metastatic pancreatic cancer Cancer Research. 75: 4137-4137. DOI: 10.1158/1538-7445.Am2015-4137  0.471
2014 Bozic I, Nowak MA. Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers. Proceedings of the National Academy of Sciences of the United States of America. 111: 15964-8. PMID 25349424 DOI: 10.1073/Pnas.1412075111  0.555
2013 Bozic I, Nowak MA. Cancer. Unwanted evolution. Science (New York, N.Y.). 342: 938-9. PMID 24264980 DOI: 10.1126/Science.1247887  0.553
2013 Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, Moon YS, Yaqubie A, Kelly N, Le DT, Lipson EJ, Chapman PB, Diaz LA, Vogelstein B, Nowak MA. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife. 2: e00747. PMID 23805382 DOI: 10.7554/Elife.00747  0.575
2013 Reiter JG, Bozic I, Allen B, Chatterjee K, Nowak MA. The effect of one additional driver mutation on tumor progression. Evolutionary Applications. 6: 34-45. PMID 23396615 DOI: 10.1111/Eva.12020  0.554
2013 Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, Moon YS, Yaqubie A, Kelly N, Le DT, Lipson EJ, Chapman PB, Diaz LA, Vogelstein B, Nowak MA. Author response: Evolutionary dynamics of cancer in response to targeted combination therapy Elife. DOI: 10.7554/Elife.00747.016  0.364
2013 Reiter JG, Bozic I, Chatterjee K, Nowak MA. TTP: Tool for tumor progression Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 8044: 101-106. DOI: 10.1007/978-3-642-39799-8_6  0.342
2012 Diaz LA, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, Allen B, Bozic I, Reiter JG, Nowak MA, Kinzler KW, Oliner KS, Vogelstein B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 486: 537-40. PMID 22722843 DOI: 10.1038/Nature11219  0.573
2012 Bozic I, Allen B, Nowak MA. Dynamics of targeted cancer therapy. Trends in Molecular Medicine. 18: 311-6. PMID 22595628 DOI: 10.1016/J.Molmed.2012.04.006  0.596
2010 Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature. 467: 1114-1117. PMID 20981102 DOI: 10.1038/Nature09515  0.583
2010 Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression Proceedings of the National Academy of Sciences of the United States of America. 107: 18545-18550. PMID 20876136 DOI: 10.1073/Pnas.1010978107  0.581
Show low-probability matches.